44. Wegener granulomatosis Clinical trials / Disease details

Clinical trials : 92 / Drugs : 106 - (DrugBank : 27) / Drug target genes : 22 - Drug target pathways : 78

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00987389 (ClinicalTrials.gov)	May 2010	23/9/2009	Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis	Plasma Exchange and Glucocorticoid Dosing in the Treatment of Anti-neutrophil Cytoplasm Antibody Associated Vasculitis: an International Randomized Controlled Trial	Granulomatosis With Polyangiitis (Wegener's) (GPA);Microscopic Polyangiitis (MPA)	Procedure: Plasma Exchange;Other: No Plasma Exchange;Drug: Glucocorticoids [Standard Dose];Drug: Glucocorticoids [Reduced Dose]	University of Pennsylvania	Cambridge University Hospitals NHS Foundation Trust;University of Birmingham;National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Completed	15 Years	N/A	All	704	Phase 3	United States;Australia;Belgium;Canada;Czechia;Denmark;France;Greece;Italy;Japan;Mexico;New Zealand;Norway;Sweden;United Kingdom;Czech Republic
2	NCT03919825 (ClinicalTrials.gov)	May 2010	15/4/2019	Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids	Plasma Exchange and Glucocorticoid Dosing in the Treatment of Anti-neutrophil Cytoplasm Antibody Associated Vasculitis: an International Randomized Controlled Trial [Glucocorticoids]	Granulomatosis With Polyangiitis (Wegener's) (GPA);Microscopic Polyangiitis (MPA)	Drug: Glucocorticoids - Standard Dose;Drug: Glucocorticoids - Reduced Dose	University of Pennsylvania	NULL	Completed	15 Years	N/A	All	704	Phase 3	NULL